These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19776036)

  • 21. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings.
    Stevens WS; Scott LE; Crowe SM
    J Infect Dis; 2010 Apr; 201 Suppl 1():S16-26. PubMed ID: 20225942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV viral load monitoring in resource-limited regions: optional or necessary?
    Calmy A; Ford N; Hirschel B; Reynolds SJ; Lynen L; Goemaere E; Garcia de la Vega F; Perrin L; Rodriguez W
    Clin Infect Dis; 2007 Jan; 44(1):128-34. PubMed ID: 17143828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of HIV-1 detection in plasma specimens and dried blood spots using the Roche COBAS Ampliscreen HIV-1 test in Kisumu, Kenya.
    Okonji JA; Basavaraju SV; Mwangi J; Shiraishi RW; Odera M; Ouma K; Pitman JP; Marum LH; Ou CY; Zeh C
    J Virol Methods; 2012 Jan; 179(1):21-5. PubMed ID: 21777620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.
    Nuesch R; Ananworanich J; Sirivichayakul S; Ubolyam S; Siangphoe U; Hill A; Cooper D; Lange J; Phanuphak P; Ruxrungtham K
    Clin Infect Dis; 2005 Mar; 40(5):728-34. PubMed ID: 15714420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA amplification of the HIV-1 Pol and env regions on dried serum and plasma spots.
    Dachraoui R; Brand D; Brunet S; Barin F; Plantier JC
    HIV Med; 2008 Aug; 9(7):557-61. PubMed ID: 18557950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
    Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross-sectional study in rural Burundi.
    Calcagno A; Motta I; Milia MG; Rostagno R; Simiele M; Libanore V; Fontana S; D'Avolio A; Ghisetti V; Di Perri G; Bonora S
    Br J Clin Pharmacol; 2015 May; 79(5):801-8. PubMed ID: 25377591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring.
    Peter T; Ellenberger D; Kim AA; Boeras D; Messele T; Roberts T; Stevens W; Jani I; Abimiku A; Ford N; Katz Z; Nkengasong JN
    Lancet Infect Dis; 2017 Jan; 17(1):e26-e29. PubMed ID: 27773596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel RealTime HIV-1 Qualitative assay for the detection of HIV-1 nucleic acids in dried blood spots and plasma.
    Huang S; Erickson B; Mak WB; Salituro J; Abravaya K
    J Virol Methods; 2011 Dec; 178(1-2):216-24. PubMed ID: 21968095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.
    Garrido C; Zahonero N; Fernándes D; Serrano D; Silva AR; Ferraria N; Antúnes F; González-Lahoz J; Soriano V; de Mendoza C
    J Antimicrob Chemother; 2008 Mar; 61(3):694-8. PubMed ID: 18218644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HIV-1 RNA level estimated with plasma and DBS samples: a pilot study from India (South).
    David S; Sachithanandham J; Jerobin J; Parasuram S; Kannangai R
    Indian J Med Microbiol; 2012; 30(4):403-6. PubMed ID: 23183463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypic resistance tests in the management of the HIV-infected patient at virological failure.
    Aceti A; Carosi G
    Scand J Infect Dis Suppl; 2003; 106():61-6. PubMed ID: 15000587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
    Monleau M; Aghokeng AF; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Touré-Kane C; Truong LX; Chaix ML; Delaporte E; Ayouba A; Peeters M;
    J Clin Microbiol; 2014 Feb; 52(2):578-86. PubMed ID: 24478491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dried blood spots versus plasma for the quantification of HIV-1 RNA using the manual (PCR-ELISA) amplicor monitor HIV-1 version 1.5 assay in Yaounde, Cameroon.
    Ikomey GM; Atashili J; Okomo-Assoumou MC; Mesembe M; Ndumbe PM
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):181-4. PubMed ID: 19357423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.
    Knuchel MC; Tomasik Z; Speck RF; Lüthy R; Schüpbach J
    J Clin Virol; 2006 May; 36(1):64-7. PubMed ID: 16431154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
    Spacek LA; Shihab HM; Kamya MR; Mwesigire D; Ronald A; Mayanja H; Moore RD; Bates M; Quinn TC
    Clin Infect Dis; 2006 Jan; 42(2):252-9. PubMed ID: 16355337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.